Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US1101221083
Ticker BMY
Company BRISTOL-MYERS SQUIBB
Currency $
Price
Aware Investor Index (AII) 3.3261
Recommendation BUY
P/E 33.03
ROE 22.20 %
Capitalization 86,878,680,000 $
Dividend Yield 2.99 %
P/S 4.18
AII Position 155
P/E Position 472
ROE Position 132
Capitalization Position 96
Dividend Yield Position 226
Sales 20,776,000,000 $
10-Year Average Earnings 2,630,300,000 $
Shares Outstanding 1,652,000,000
Equity 11,847,000,000 $
Dividend per Share 1.57 $
Industry Pharmaceutical
Country United States
BRISTOL-MYERS SQUIBB Investor Relations Web Site https://www.bms.com/investors.html







Sales:

YEAR MONTH AMOUNT
2017 12 20,776,000,000.00 $
2016 12 19,427,000,000.00 $
2015 12 16,560,000,000.00 $
2014 12 15,879,000,000.00 $
2013 12 16,385,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 1,007,000,000.00 $
2016 12 4,457,000,000.00 $
2015 12 1,565,000,000.00 $
2014 12 2,004,000,000.00 $
2013 12 2,563,000,000.00 $
2012 12 1,960,000,000.00 $
2011 12 3,709,000,000.00 $
2010 12 3,102,000,000.00 $
2009 12 3,239,000,000.00 $
2008 12 2,697,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 11,847,000,000.00 $
2016 12 16,347,000,000.00 $
2015 12 14,424,000,000.00 $
2014 12 14,983,000,000.00 $
2013 12 15,236,000,000.00 $
2012 12 13,638,000,000.00 $
2011 12 15,867,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,785,000,000.00 $
2008 12 12,208,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 1,652,000,000
2016 12 1,680,000,000
2015 12 1,679,000,000
2014 12 1,670,000,000
2013 12 1,662,000,000
2012 12 1,688,000,000
2011 12 1,717,000,000
2010 12 1,727,000,000
2009 12 1,978,000,000
2008 12 1,999,000,000

 












Bloomberg News for BRISTOL-MYERS SQUIBB:



Google News for BRISTOL-MYERS SQUIBB:

The RNS Daily - 41 minutes ago
Bristol-Myers Squibb Company (BMY): This Isn't A Speed Bump
The average 12-month price target analysts expect from Bristol-Myers Squibb Company (NYSE:BMY) is $59.53. This mean price target ...
NMSU Nеws
Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What ...
Bristol-Myers Squibb (BMY) closed at $52.81 in the latest trading session, marking a -0.34% move from the prior day. This change lagged the ...
Top Stocks News (press release)
Bristol-Myers Squibb (BMY) Q3 2018 Results - Earnings Call ...
Bristol-Myers Squibb Co. (NYSE:BMY) Q3 2018 Earnings Call October 25, 2018 10:30 AM ET. Executives. John E. Elicker - Bristol-Myers ...
Motley Fool
Recent Purchase: Bristol-Myers Squibb
Over the last couple of years, I've had success trading into and out of Bristol-Myers Squibb (BMY) stock. It's fairly rare that I buy shares with a ...
Yahoo Finance - 5 days ago
Infinity Pharma teams up with Bristol-Myers Squibb in urothelial cancer
Bristol-Myers Squibb (NYSE:BMY) and Infinity Pharmaceuticals (NASDAQ:INFI) will collaborate on a clinical trial evaluating the combination of ...
Simply Wall St
Bouncing back from collapse: Bristol-Myers Squibb Company (BMY ...
The share price of Bristol-Myers Squibb Company (NYSE: BMY) has taken quite a journey since the beginning of the year, with a year-to-date ...
FDA Headlines
Bristol-Myers Squibb (BMY) Announces Approves Empliciti Plus ...
Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Empliciti ...
Fairfield Current
Latest Technicals: – Bristol-Myers Squibb Company, (NYSE: BMY)
On 13-11-2018 (Tuesday), the Healthcare stock (Bristol-Myers Squibb Company) created a change of -0.49 percent and closed its last session ...
Seeking Alpha - 25 Oct 2018
Bristol-Myers Squibb under pressure on positive data for Keytruda + ...
Bristol-Myers Squibb (BMY -3.4%) is under water in early trade in apparent response to Merck's announcement of successful Phase 3 results ...
Zacks.com
Bristol-Myers Squibb down 3% premarket on diminished prospects ...
Bristol-Myers Squibb (NYSE:BMY) slips 3% premarket on light volume following a downgrade to Neutral ($57 price target) at Citigroup. Analyst ...


Back